Cite
HARVARD Citation
Hsu, J. et al. (2022). Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges. JCO precision oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hsu, J. et al. (2022). Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges. JCO precision oncology. p. . [Online].